May Hegglin anomaly: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 30: | Line 30: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Hematology}} | {{Hematology}} | ||
Latest revision as of 19:28, 4 September 2012
| May Hegglin anomaly | |
| ICD-10 | D72.0 |
|---|---|
| ICD-9 | 288.2 |
| OMIM | 155100 |
| DiseasesDB | 29517 |
| eMedicine | ped/1383 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
May Hegglin's anomaly, as it is also known, is a rare genetic disorder of the blood platelets that causes them to be abnormally large. Also, this anomaly causes abnormalities in the white blood cells known as leukocytes.
Presentation
In the leukocytes, the presence of very small rods (around 3 micrometers), or Dohle bodies can be seen in the cytoplasm.
Treatment
In many cases, May Hegglin's requires no treatment. However, in extreme cases, blood platelet transfusions may be necessary
Causes
An association with MYH9 has been described.[1]
References
- ↑ Saito H, Kunishima S (2007). "Historical hematology: May-Hegglin anomaly". Am J Hematol. doi:10.1002/ajh.21102. PMID 17975807.